It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both. The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor. Zacks Premium also includes the Zacks Style Score ...

Investors remain in the midst of one of the greatest bullish moves in history. The S&P 500 has risen in 16 of the past 19 weeks, advancing about 25% over that stretch. It’s a remarkable feat that has only occurred a handful of times in the past. Coming off this historic run, market participants may feel cautious and question if this rally has more legs. Tech stocks have led the way throughout this new bull market, bolstered by an artificial intelligence theme that caught many investors off guard. As the ral ...

In the latest trading session, Abbott (ABT) closed at $120.76, marking a +0.47% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 1.12% for the day. At the same time, the Dow added 0.61%, and the tech-heavy Nasdaq gained 1.54%. Shares of the maker of infant formula, medical devices and drugs witnessed a gain of 6.81% over the previous month, beating the performance of the Medical sector with its gain of 2.49% and the S&P 500's gain of 2.06%. Market participants will ...

In the latest market close, Abbott (ABT) reached $120.19, with a -0.64% movement compared to the previous day. The stock fell short of the S&P 500, which registered a loss of 0.11% for the day. Meanwhile, the Dow gained 0.12%, and the Nasdaq, a tech-heavy index, lost 0.41%. Prior to today's trading, shares of the maker of infant formula, medical devices and drugs had gained 8.18% over the past month. This has outpaced the Medical sector's gain of 3.03% and the S&P 500's gain of 2.7% in that time. The invest ...

A dividend is more than passive income to investors. It's a sign of confidence from management in the business itself. After all, management probably wouldn't give you that cash to shareholders if they felt the company needed it more. Do you know what's better than a dividend? A rising dividend. Increasing the amount a company pays is the ultimate vote of confidence. These are the businesses you want to buy and hold. Healthcare is a multitrillion-dollar industry, but a few familiar faces have excelled for d ...

Abbott Laboratories, Inc. (ABT) recently extended its partnership with Real Madrid and the Real Madrid Foundation through Real Madrid's 2026-27 season. First established in 2021, Abbott will remain the Global Health Sciences and Nutrition Partner of Real Madrid Football Club and the Global Partner of the Real Madrid Foundation. The partnership aims to put a check on childhood malnutrition and promote healthy habits for future generations. Fostering Health and Nutrition Together The collaboration with the Re ...

股价表现 - Abbott（ABT）最近的股价为$118.48，较前一个交易日下跌了1.3%[1] - Abbott的股价在过去一个月上涨了7.51%，领先医疗行业的增长率4.07%和标普500指数的增长率3.64%[2] 财报预期 - 投资者将密切关注Abbott即将发布的财报表现。预计公司将报告每股收益为$0.96，较去年同期下降了6.8%。同时，最新的共识估计预计营收为98.5亿美元，较去年同期增长了1.02%[3] - 根据Zacks Consensus Estimates，整个财年预计每股收益为4.62美元，营收为419亿美元，分别较上一年增长了+4.05%和+4.47%[4] 估值和评级 - 近期分析师对Abbott的估值也有所变化。近期的修订往往反映了最新的短期业务趋势。因此，我们可以将积极的估值修订解读为公司业务前景的良好迹象[5] - 研究表明，这些估值调整直接与即将到来的股价表现相关。投资者可以利用Zacks Rank来实现这一点。该模型考虑这些估值变化，并提供一个简单、可操作的评级系统[6] - Zacks Rank系统从1（强热门）到5（强卖出），经第三方审计验证，表现出色，自1988年以来，排名为1的股票的平均年回报率为+25%。过去一个月，Zacks共识EPS估计下调了0.01%。目前，Abbott的Zacks Rank为3（持有）[7] 行业比较 - 从估值角度来看，Abbott目前的前瞻市盈率为26，较行业平均前瞻市盈率20.84有溢价[8] - 还需注意的是，ABT目前的PEG比率为2.89。PEG比率类似于广泛使用的市盈率，但该指标还考虑了公司的预期盈利增长率。截至昨日收盘，ABT所在行业的平均PEG比率为2.68[9] 行业排名 - 医疗产品行业属于医疗行业。目前，该行业的Zacks行业排名为152，位于250多个行业中的后40%[10] - Zacks行业排名通过计算各个股票的平均Zacks Rank来评估特定行业群体的活力。我们的研究显示，排名前50%的行业的表现比后50%的行业好2倍。您可以在Zacks.com上找到有关所有这些指标以及更多信息[11]

Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past month, shares of this maker of infant formula, medical devices and drugs have returned +5.8%, compared to the Zacks S&P 500 composite's +4.8% change. During this period, the Zacks Medical - Products industry, which Abbott falls in, has gained 0.6%. The key question now is: What could be the stock's future direc ...

Anti-obesity drugs rose in popularity last year, helping the leaders in this market -- notably Eli Lilly and Novo Nordisk -- crush the market. However, some medical device specialists got the wrong end of the stick. That was the case with Abbott Laboratories (ABT -0.02%), whose diabetes care segment is perceived as its most important growth driver. Some investors thought GLP-1 medicines such as Ozempic could decrease demand for some of Abbott's key products. But that's not the case. Anti-obesity medicines w ...

Nearing retirement can feel freeing. You've worked your entire career for this! Naturally, the stressful part of retiring is protecting your saved money. It's arguably more important to prevent steep losses than to continue building wealth. While no stock or investment is risk-free, you can find blue-chip stocks in industries like healthcare that will always be in demand because they're a pillar of modern society. Here are three fabulous healthcare stocks with ironclad financials. You can buy and hold these ...